MeSH D010051 - ovarian neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005833:Female genital neoplasms
0 Companies
0 Drugs
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010049:Ovarian diseases
0 Companies
0 Drugs
Success rate
D010051:Â
Ovarian neoplasms
D000077216:Ovarian epithelial carcinoma
D001948:Brenner tumor
0 Companies
0 Drugs
Success rate
D006106:Granulosa cell tumor
0 Companies
0 Drugs
Success rate
D008539:Meigs syndrome
0 Companies
0 Drugs
Success rate
D013798:Thecoma
0 Companies
0 Drugs
Success rate
D018269:Endometrioid carcinoma
0 Companies
0 Drugs
Success rate
D018310:Sertoli-leydig cell tumor
0 Companies
0 Drugs
Success rate
D018311:Luteoma
0 Companies
0 Drugs
Success rate
D061325:Hereditary breast and ovarian cancer syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Leuprolide, Norethindrone | Lupaneta Pack |  | 2012-12-14 |  |  |
| Leuprolide | Lupron |  | 1985-04-09 | $783 M | Y2021 | |
| Leuprolide | Lupron Depot |  | 1989-01-26 |  |  | |
| Leuprolide | Lupron Depot-ped | 2028-03-22 | 1993-04-16 |  |  | |
| Accord Healthcare | Leuprolide | Camcevi | 2027-01-16 | 2021-05-25 |  |  |
| Carboplatin | Carboplatin |  | 2017-02-09 |  |  | |
| Docetaxel | Docetaxel |  | 2011-06-08 |  |  | |
| Docetaxel | Docetaxel Accord |  | 2012-05-22 |  |  | |
| Gemcitabine | Gemcitabine |  | 2011-07-25 |  |  | |
| Oxaliplatin | Oxaliplatin |  | 2017-03-21 |  |  | |
| Paclitaxel | Paclitaxel |  | 2004-11-12 |  |  | |
| Topotecan | Topotecan |  | 2013-06-26 |  |  | |
| Doxorubicin | Zolsketil pegylated |  | 2022-05-31 |  |  | |
| Cisplatin | Cisplatin |  | 2015-08-18 |  |  | |
| ACIC Pharmaceuticals | Docetaxel | Docetaxel |  | 2024-02-28 |  |  |
| Acrotech Biopharma | Melphalan | Evomela | 2029-03-13 | 2016-03-10 |  |  |
| Adienne | Melphalan | Phelinun |  | 2020-11-16 |  |  |
| Thiotepa | Tepadina |  | 2017-01-26 |  |  | |
| Alembic Pharmaceuticals | Cyclophosphamide | Cyclophosphamide |  | 2022-11-10 |  |  |
| Paclitaxel | Paclitaxel |  | 2022-10-20 |  |  | |
| Docetaxel | Docetaxel |  | 2023-02-28 |  |  | |
| Allergan | Carboplatin | Carboplatin |  | 2004-10-14 |  |  |
| Docetaxel | Docetaxel |  | 2013-04-12 |  |  | |
| Doxorubicin | Doxorubicin |  | 2014-06-27 |  |  | |
| Gemcitabine | Gemcitabine |  | 2011-07-25 |  |  | |
| Melphalan | Melphalan |  | 2016-12-19 |  |  | |
| Oxaliplatin | Oxaliplatin |  | 2012-08-08 |  |  | |
| Paclitaxel | Paclitaxel |  | 2009-12-09 |  |  | |
| Topotecan | Potactasol |  | 2011-01-06 |  |  | |
| Topotecan | Topotecan |  | 2010-12-02 |  |  | |
| Topotecan | Topotecan Actavis |  | 2009-07-24 |  |  | |
| Vinorelbine | Vinorelbine |  | 2009-07-22 |  |  | |
| Alvogen | Melphalan | Melphalan |  | 2017-03-22 |  |  |
| American Regent | Gemcitabine | Gemcitabine |  | 2013-05-07 |  |  |
| Oxaliplatin | Oxaliplatin |  | 2017-05-12 |  |  | |
| Paclitaxel | Paclitaxel |  | 2022-07-27 |  |  | |
| Amgen | Bevacizumab | Mvasi |  | 2017-09-14 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
75%182/243
Phase 2
25%74/296
Phase 3
37%49/133
Approved: 31Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use